Monday, 27 June, 2022
HomeHealthSwiss firm launches 5-minute blood test to screen patients most at risk...

Swiss firm launches 5-minute blood test to screen patients most at risk from Covid

Abionic SA said a low score on the test can allow doctors to discharge patients or shift them from intensive care to the general ward faster.

Text Size:

Bern: A Swiss firm has introduced a blood test that can help hospitals more quickly pinpoint patients at risk of a severe form of Covid-19 as doctors seek ways to triage and prioritize medical treatment.

Abionic SA said Thursday its method can be performed without medical training on a drop of capillary blood and gives results in five minutes. The Lausanne, Switzerland-based company said a low score can allow doctors to discharge patients from the hospital or shift them from intensive care to the general ward.

The company said its cSOFA score is an improvement from a method that’s used throughout hospitals already. The process, which looks for a biomarker called pancreatic stone protein, has approval for sale in Europe.

Intensive care units filled up in the most recent surge of infections in Europe. While ward occupancy has come down in France and Belgium, Sweden has reached its highest level since June. – Bloomberg


Also read: Some patients face vision loss, blurry eyesight post-Covid. Doctors can’t confirm link yet


 

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism

Most Popular

×